Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Meiji Launches 2 Santen Eye Drugs in Indonesia
August 8, 2019
- Life Science Institute’s Muse Cell Product Processing Facility Bags Manufacturing License
August 8, 2019
- Japan Ethical Drug Sales Up 0.2% in June: Crecon
August 8, 2019
- Novartis’ Entresto Filed in Japan for Chronic Heart Failure
August 7, 2019
- Keytruda Top-Selling Drug in Japan in April-June: IQVIA
August 7, 2019
- PIII Gets Underway for Astellas’ Hot Flash Drug Fezolinetant
August 7, 2019
- Mitsubishi Tanabe, Jichi Medical Univ. to Commence AMED-Funded Hemophilia Gene Therapy Research
August 7, 2019
- Rohto President “Frustrated” with Slow Pace of Rx-to-OTC Switches in Japan
August 7, 2019
- Suzuken, SanBio Join Forces for Commercial Distribution of Stem Cell Therapy
August 7, 2019
- Keytruda Keeps Top Spot in Drug Sales Ranking in July: Encise
August 7, 2019
- Gearing Up for Japan Debut, Daiichi Sankyo Mounting Push for AML Med Vanflyta
August 6, 2019
- Daiichi Sankyo’s Pexidartinib Bags 1st FDA Nod for Rare Joint Tumor
August 6, 2019
- Fujifilm Completes Buyout of Biogen Manufacturing Unit, Tripling Its Bioreactor Capacity
August 6, 2019
- Ferring to Copromote Regenerative Medicine Product for Fertility Care Facilities
August 6, 2019
- Sosei, Takeda Seal Multi-Target Collaboration Deal
August 6, 2019
- AstraZeneca’s Japan Sales Surge 28% in H1 on Oncology Growth
August 6, 2019
- Rakuten Ups Its Stake in Rakuten Medical to 22.6%
August 5, 2019
- Gene Panel Testing Should Be Done “at an Early Stage”: Chugai Official
August 5, 2019
- Daiichi Sankyo Upping Pitches for Tarlige in May: Impact Track Survey
August 2, 2019
- Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO
August 2, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…